Cancer of the Lung
18
3
4
7
Key Insights
Highlights
Success Rate
58% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
27.8%
5 terminated out of 18 trials
58.3%
-28.2% vs benchmark
0%
0 trials in Phase 3/4
43%
3 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (18)
Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital
Precision Lung Cancer Survivorship Care Intervention
Microwave Ablation in Chinese Patients With Lung Tumors
Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma
MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)
A Phase I Study of iPS Cell Generation From Patients With COPD
Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer
NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung
NEUWAVE Flexible Probe Study #2
Investigating the Improvement in 4D CT Images Using AV Biofeedback
A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System
Circulating Tumor DNA in Patients at High Risk for Lung Cancer
The Efficacy and Safety of Electronic Cigarettes: a 5-year Follow-up Study
Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer
Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation
LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy